Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial

Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial

To investigate the effect of a fermented soy supplement during 18 months in patients under active surveillance (AS) for low-risk and selected favorable intermediate-risk prostate cancer (PCa), with an emphasis on PSA modulation. Low-risk patients with ISUP grade 1, clinical stage cT1 or cT2a, PSA &l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2024-10, Vol.16 (21), p.3634
Hauptverfasser: Van der Eecken, Hans, De Cock, Diederik, Roussel, Eduard, Giesen, Alexander, Vansevenant, Bram, Goeman, Lieven, Quackels, Thierry, Joniau, Steven
Format: Artikel
Sprache:eng
Schlagworte:
Biopsy
Cancer
Dietary supplements
Dutasteride
Isoflavones
Magnetic resonance imaging
Oncology, Experimental
Pathology
Prevention
Prostate cancer
Prostate carcinoma
Sensitivity analysis
Soybeans
Surveillance
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To investigate the effect of a fermented soy supplement during 18 months in patients under active surveillance (AS) for low-risk and selected favorable intermediate-risk prostate cancer (PCa), with an emphasis on PSA modulation. Low-risk patients with ISUP grade 1, clinical stage cT1 or cT2a, PSA < 10 ng/mL and favorable intermediate-risk patients with ISUP grade 2 (
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers16213634